Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybin
No abstract is available for this record.
Bibliographic context
Authors
Watch authorTopics and keywords
psilocybin PharmacologyClinical TrialSafetyToxicity Clinical Trial PsilocybinMDMACredibilityMedicineProtocol (science)Psychological interventionClinical trialTransparency (behavior)Consistency (knowledge bases)ChecklistReporting biasDocumentationPsychiatryMEDLINEProtocol designMephedroneConsolidated Standards of Reporting TrialsAlternative medicineHallucinogenClinical pharmacology
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
No close related records were found yet.